Cart
sales@molnova.com
Cyclophosphamide hydrate
CAS No. 6055-19-2
Cyclophosphamide hydrate ( Cyclophosphamide monohydrate )
Catalog No. M15264 CAS No. 6055-19-2
A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities; used to treat cancers and autoimmune diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 30 | In Stock |
|
| 100MG | 42 | In Stock |
|
| 200MG | 52 | In Stock |
|
| 500MG | 78 | In Stock |
|
| 1G | 120 | In Stock |
|
Biological Information
-
Product NameCyclophosphamide hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionA synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities; used to treat cancers and autoimmune diseases.
-
DescriptionA synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities; used to treat cancers and autoimmune diseases.Chemotherapeutic Agents Approved
-
SynonymsCyclophosphamide monohydrate
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA;MRP1
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number6055-19-2
-
Formula Weight279.10
-
Molecular FormulaC7H17Cl2N2O3P
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 38 mg/mL
-
SMILESO.ClCCN(CCCl)P1(=O)NCCCO1
-
Chemical Name2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, hydrate (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Clofazimine
Clofazimine is a fat-soluble iminophenazine dye, has a marked anti-inflammatory effect, has been used in combination with other antimycobacterial drugs to treat AIDS and Crohn's disease.
-
KCC-07
KCC-07 is a selective, potent and brain-penetrant inhibitor of methyl-CpG-binding domain protein 2(MBD2) with anticancer activity.
-
Glufosfamide
A conjugate of glucose and active alkylating moiety of ifosfamide with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters.
